BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 15829161)

  • 1. Effects of adenosine and adenosine A2A receptor agonist on motor nerve conduction velocity and nerve blood flow in experimental diabetic neuropathy.
    Kumar S; Arun KH; Kaul CL; Sharma SS
    Neurol Res; 2005 Jan; 27(1):60-6. PubMed ID: 15829161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute hyperglycemia attenuates nerve conduction velocity and nerve blood flow in male Sprague-Dawley rats: reversal by adenosine.
    Saini AK; Arun KH; Kaul CL; Sharma SS
    Pharmacol Res; 2004 Dec; 50(6):593-9. PubMed ID: 15501697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of resveratrol on nerve functions, oxidative stress and DNA fragmentation in experimental diabetic neuropathy.
    Kumar A; Kaundal RK; Iyer S; Sharma SS
    Life Sci; 2007 Mar; 80(13):1236-44. PubMed ID: 17289084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissection of metabolic, vascular, and nerve conduction interrelationships in experimental diabetic neuropathy by cyclooxygenase inhibition and acetyl-L-carnitine administration.
    Pop-Busui R; Marinescu V; Van Huysen C; Li F; Sullivan K; Greene DA; Larkin D; Stevens MJ
    Diabetes; 2002 Aug; 51(8):2619-28. PubMed ID: 12145179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of M40403 treatment of diabetic rats on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve.
    Coppey LJ; Gellett JS; Davidson EP; Dunlap JA; Lund DD; Salvemini D; Yorek MA
    Br J Pharmacol; 2001 Sep; 134(1):21-9. PubMed ID: 11522593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of U83836E on nerve functions, hyperalgesia and oxidative stress in experimental diabetic neuropathy.
    Sayyed SG; Kumar A; Sharma SS
    Life Sci; 2006 Jul; 79(8):777-83. PubMed ID: 16581090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminoguanidine--effects on endoneurial vasoactive nitric oxide and on motor nerve conduction velocity in control and streptozotocin-diabetic rats.
    Dewhurst M; Omawari N; Tomlinson DR
    Br J Pharmacol; 1997 Feb; 120(4):593-8. PubMed ID: 9051296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-ca rboxamid e (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats.
    Mizuno K; Kato N; Matsubara A; Nakano K; Kurono M
    Metabolism; 1992 Oct; 41(10):1081-6. PubMed ID: 1328819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve.
    Coppey LJ; Gellett JS; Davidson EP; Dunlap JA; Lund DD; Yorek MA
    Diabetes; 2001 Aug; 50(8):1927-37. PubMed ID: 11473057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amelioration of diabetic peripheral neuropathy by implantation of hematopoietic mononuclear cells in streptozotocin-induced diabetic rats.
    Hasegawa T; Kosaki A; Shimizu K; Matsubara H; Mori Y; Masaki H; Toyoda N; Inoue-Shibata M; Nishikawa M; Iwasaka T
    Exp Neurol; 2006 Jun; 199(2):274-80. PubMed ID: 16337192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats.
    Cameron NE; Cotter MA; Archibald V; Dines KC; Maxfield EK
    Diabetologia; 1994 May; 37(5):449-59. PubMed ID: 8056181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of trolox on nerve dysfunction, thermal hyperalgesia and oxidative stress in experimental diabetic neuropathy.
    Sharma SS; Sayyed SG
    Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1022-8. PubMed ID: 17042909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tanshinone IIA improves impaired nerve functions in experimental diabetic rats.
    Liu Y; Wang L; Li X; Lv C; Feng D; Luo Z
    Biochem Biophys Res Commun; 2010 Aug; 399(1):49-54. PubMed ID: 20637731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cilostazol on experimental diabetic neuropathy in the rat.
    Kihara M; Schmelzer JD; Low PA
    Diabetologia; 1995 Aug; 38(8):914-8. PubMed ID: 7589876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy.
    Nagamatsu M; Nickander KK; Schmelzer JD; Raya A; Wittrock DA; Tritschler H; Low PA
    Diabetes Care; 1995 Aug; 18(8):1160-7. PubMed ID: 7587852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a potent new aldose reductase inhibitor, (5-(3-thienyltetrazol-1-yl)acetic acid (TAT), on diabetic neuropathy in rats.
    Hotta N; Kakuta H; Fukasawa H; Koh N; Sakakibara F; Nakamura J; Hamada Y; Wakao T; Hara T; Mori K
    Diabetes Res Clin Pract; 1995 Feb; 27(2):107-17. PubMed ID: 7607048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depletion of taurine in experimental diabetic neuropathy: implications for nerve metabolic, vascular, and functional deficits.
    Pop-Busui R; Sullivan KA; Van Huysen C; Bayer L; Cao X; Towns R; Stevens MJ
    Exp Neurol; 2001 Apr; 168(2):259-72. PubMed ID: 11259114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylcholine-induced arteriolar dilation is reduced in streptozotocin-induced diabetic rats with motor nerve dysfunction.
    Terata K; Coppey LJ; Davidson EP; Dunlap JA; Gutterman DD; Yorek MA
    Br J Pharmacol; 1999 Oct; 128(3):837-43. PubMed ID: 10516670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An aldose reductase inhibitor, TAT, reduces ADP-induced platelet hyperaggregation in streptozotocin-induced diabetic rats with neuropathy.
    Hara T; Nakamura J; Koh N; Sakakibara F; Hamada Y; Sasaki H; Naruse K; Nakashima E; Takeuchi N; Inukai S
    J Lab Clin Med; 1995 Dec; 126(6):541-7. PubMed ID: 7490513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angelica injection promotes peripheral nerve structure and function recovery with increased expressions of nerve growth factor and brain derived neurotrophic factor in diabetic rats.
    Li R; Zhang J; Zhang L; Cui Q; Liu H
    Curr Neurovasc Res; 2010 Aug; 7(3):213-22. PubMed ID: 20560879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.